Top

Langenbeck's Archives of Surgery

Published in:

01-11-2010 | Original Article

Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection

Results of the quality assurance in rectal cancer surgery multicenter observational trial

Authors: Benjamin Garlipp, Henry Ptok, Uwe Schmidt, Frank Meyer, Ingo Gastinger, Hans Lippert

Published in: Langenbeck's Archives of Surgery | Issue 8/2010

Abstract

Introduction

Randomized trials have demonstrated a reduction in local recurrence rate in rectal cancer patients treated with preoperative chemoradiotherapy and total mesorectal excision (TME) compared to patients undergoing TME alone. Accordingly, preoperative chemoradiotherapy in all UICC stages II and III rectal cancers has been recommended in the German treatment guidelines as of 2004. However, this policy has been questioned in recent years, partly due to concern regarding an increase in postoperative complications through preoperative therapy. Studies on this issue are sparse; most have been conducted in specialized centers, included relatively few patients, and yielded partly contradicting results. It was the aim of our analysis to investigate the influence of preoperative chemoradiotherapy on anastomotic leak rate and postoperative bladder dysfunction in rectal cancer patients using a representative data set from the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.

Method

This is a retrospective analysis of data from the Quality Assurance in Rectal Cancer Surgery prospective multicenter observational trial. Data of all patients undergoing curatively intended sphincter-preserving resection for UICC stage I through III rectal carcinoma between 01 Jan 2005 and 31 Dec 2007 with or without preoperative chemoradiotherapy (groups A and B, respectively) were included. Multivariate statistical analysis using propensity score analysis was carried out regarding outcome parameters total anastomotic leak rate, rate of anastomotic leaks requiring reoperation, and postoperative bladder dysfunction.

Results

A total of 2,085 patients were included (group A, n = 676, group B, n = 1,409). Significant differences were present between groups regarding age, sex, distance of the tumor from the anal verge, pT-stage, UICC stage, hepatic risk factors, and use of protective enterostomy by univariate analysis. Multivariate logistic regression including these parameters was used to calculate the propensity score (likelihood to be assigned to group A or B as a consequence of the individual profile of these factors) for each patient. When outcome parameters were compared between groups A and B after stratification for propensity score, no significant differences regarding postoperative bladder dysfunction (p = 0.12), total anastomotic leak rate (p = 0.56), and anastomotic leaks requiring reoperation (p = 0.56) could be demonstrated.

Conclusion

Neoadjuvant chemoradiotherapy for rectal carcinoma does not increase the risk for anastomotic leakage or postoperative bladder dysfunction after curatively intended sphincter-preserving rectal resection.

Stockholm Rectal Cancer Study Group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66:49–55CrossRef

Stockholm Colorectal Cancer Study Group (1996) Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 3:423–430CrossRef

Swedish Rectal Cancer Trial (1996) Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 162:397–402

Colorectal cancer collaborative group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8, 507 patients from 22 randomised trials. Lancet 358:1291–1304CrossRef

Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M (2000) Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284:1008–1015CrossRefPubMed

Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646CrossRefPubMed

Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens J, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed

Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rödel C, Sauer R, Wieser M, Schmitt W, Schmoll H, Seufferlein T, Kopp I, Pox C (2008) Update S3-guideline “colorectal cancer” 2008. Z Gastroenterol 46:799–840CrossRefPubMed

Ulrich A, Schwerdt J, Z’graggen K, Kienle P, Weitz J, Büchler MW (2007) Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists. Langenbecks Arch Surg 392:525–533CrossRefPubMed

10.

Junginger T, Hermanek P, Oberholzer K, Schmidberger H (2006) Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication. Zentralbl Chir 131:275–284PubMed

11.

Ulrich A, Weitz J, Büchler MW (2009) Rectal cancer. How much radiotherapy do surgery patients need? Chirurg 80:266–273CrossRefPubMed

12.

Birgisson H, Påhlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126–6131CrossRefPubMed

13.

Pollack J, Holm T, Cedermark B, Altman D, Holmström B, Glimelius B, Mellgren A (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93:1519–1525CrossRefPubMed

14.

Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Nordijk EM, van Krieken JH, van de Velde CJ, Leer JW, Cooperative investigators of the Dutch Colorectal Cancer Group (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311–1320PubMed

15.

Peeters KCMJ, van de Velde CJH, Leer JWH, Martijn H, Junggeburt JMC, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CAM (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23:6199–6206CrossRefPubMed

16.

Marijnen CAM, Kapiteijn E, van de Velde CJH, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JWH (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20:817–825CrossRefPubMed

17.

Akiyoshi T, Kuroyanagi H, Oya M, Konishi T, Fukuda M, Fujimoto Y, Ueno M, Yamaguchi T, Muto T (2009) Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy. J Gastrointest Surg 13:521–525CrossRefPubMed

18.

Horisberger K, Hofheinz RD, Palma P, Volkert AK, Rothenhoefer S, Wenz F, Hochhaus A, Post S, Willeke F (2008) Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis 23:257–264CrossRefPubMed

19.

Rosati R, Bona S, Romario UF, Elmore U, Furlan N (2007) Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy. Surg Oncol 16(Suppl 1):S83–S89CrossRefPubMed

20.

Lyall A, Mc Adam TK, Townend J, Loudon MA (2007) Factors affecting anastomotic complications following anterior resection in rectal cancer. Colorectal Dis 9:801–807CrossRefPubMed

21.

Valenti V, Hernandez-Lizoain JL, Baixauli J, Pastor C, Aristu J, Diaz-Gonzalez J, Beunza JJ, Alvarez-Cienfuegos JA (2007) Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy. Ann Surg Oncol 14:1744–1751CrossRefPubMed

22.

Buie WD, MacLean AR, Attard JP, Brasher PMA, Chan AK (2005) Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer. Dis Colon Rectum 48:1868–1874CrossRefPubMed

23.

Turner II, Russell GB, Blackstock AW, Levine EA (2004) Impact of neoadjuvant therapy on postoperative complications in patients undergoing resection for rectal adenocarcinoma. Am Surg 70:1045–1049PubMed

24.

Valero G, Luján JA, Hernández Q, De Las Heras M, Pellicer E, Serrano A, Parrilla P (2003) Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis 18:495–499CrossRefPubMed

25.

Martel G, Al-Suhaibani Y, Moloo H, Haggar F, Friedlich M, Mamazza J, Poulin EC, Stern H, Boushey RP (2008) Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer. Dis Colon Rectum 51:1195–1201CrossRefPubMed

26.

Ulrich A, Weitz J, Slodczyk M, Koch M, Jaeger D, Münter M, Büchler MW (2009) Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgery. Int J Radiat Oncol Biol Phys 75:129–136PubMed

27.

Urso E, Serpentini S, Pucciarelli S, de Salvo GL, Friso ML, Fabris G, Lonardi S, Ferraro B, Bruttocao A, Aschele C, Nitti D (2006) Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 32:1201–1208CrossRefPubMed

28.

Stumpf M, Junge K, Wendlandt M, Krones C, Ulmer F, Klinge U, Schumpelick V (2009) Risk factors for anastomotic leakage after colorectal surgery. Zentralbl Chir 134:242–248CrossRefPubMed

29.

Junginger T, Kneist W, Sultanov F, Heintz A (2003) Indicators of quality in surgical treatment of rectal carcinoma. Chirurg 74:444–450, discussion 450-1CrossRefPubMed

30.

Junginger T, Kneist W, Heintz A (2003) Influence of identification and preservation of pelvic autonomic nerves in rectal cancer surgery on bladder dysfunction after total mesorectal excision. Dis Colon Rectum 46:621–628CrossRefPubMed

31.

Maurer CA, Z’Graggen K, Renzulli P, Schilling MK, Netzer P, Büchler MW (2001) Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 88:1501–1505CrossRefPubMed

32.

Bonnel C, Parc YR, Pocard M, Dehni N, Caplin S, Parc R, Tiret E (2002) Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 45:934–939CrossRefPubMed

33.

Heriot AG, Tekkis PP, Fazio VW, Neary P, Lavery IC (2005) Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg 242:502–510, discussion 510–511PubMed

34.

Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Di Renzo V (2009) observational studies: propensity score analysis of non-randomized data. Int MS J 16:90–97PubMed

35.

Matthiessen P, Hallböök O, Andersson M, Rutegård J, Sjödahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 6:462–469CrossRefPubMed

36.

Holm T, Singnomklao T, Rutqvist LE, Cedermark B (1996) Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 78:968–976CrossRefPubMed

37.

Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin-Ståhl E (2003) A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42:476–492CrossRefPubMed

38.

Krones CJ, Stumpf M, Schumpelick V (2009) Surgery for rectal cancer. Chirurg 80:303–310CrossRefPubMed

39.

Strassburg J, Lewin A, Ludwig K, Kilian L, Linke J, Loy V, Knuth P, Püttcher O, Ruehl U, Stöckmann F, Hackenthal M, Hopfenmüller W, Huppertz A (2007) Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg 392:179–188CrossRefPubMed

Title: Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection
Results of the quality assurance in rectal cancer surgery multicenter observational trial
Authors: Benjamin Garlipp
Henry Ptok
Uwe Schmidt
Frank Meyer
Ingo Gastinger
Hans Lippert
Publication date: 01-11-2010
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 8/2010
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-010-0708-0

At a glance: The STEP trials

Springer Medicine

Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection

Results of the quality assurance in rectal cancer surgery multicenter observational trial

Abstract

Introduction

Method

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2010

Single-incision laparoscopic TAPP mesh hernioplasty using conventional instruments: an evolving technique

Defect classification and reconstruction algorithm for patients with tracheostomy using the tunneled supraclavicular artery island flap

Intraoperative laser fluorescence angiography in colorectal surgery: a noninvasive analysis to reduce the rate of anastomotic leakage

Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer

Adult hepatoblastoma successfully treated with multimodal treatment

Surgical treatment for gastric cancer in Turkish patients over age 70: early postoperative results and risk factors for mortality